Neurobiology of Aging
Volume 27, Issue 12 , Pages 1797-1806 , December 2006

Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan

  • P.N. Wang

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taiwan
    • The Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan
    • ,
  • J.F Lirng

      Affiliations

    • Department of Radiology, National Yang-Ming University School of Medicine, Taiwan
    • Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • K.N. Lin

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taiwan
    • The Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan
    • Department of Psychology, Fu Jen Catholic University, Taipei County, Taiwan
    • ,
  • F.C. Chang

      Affiliations

    • Department of Radiology, National Yang-Ming University School of Medicine, Taiwan
    • Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • H.C. Liu

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taiwan
    • The Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 2 2875 7492; fax: +886 2 2873 8696.

Received 20 March 2005 ,Revised 2 October 2005 ,Accepted 5 October 2005.

References 

  1. Amieva H, Letenneur L, Dartigues JF, Rouch-Leroyer I, Sourgen C, D’Alchee-Biree F, et al. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord. 2004;18(1):87–93
  2. Anstey KJ, Mailer JJ. The role of volumetric MRI in understanding mild cognitive impairment and similar classifications. Aging Ment Health. 2003;7(4):238–250
  3. Arnaiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand Suppl. 2003;179:34–41
  4. Artero S, Tierney MC, Touchon J, Ritchie K. Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr Scand. 2003;107(5):390–393
  5. Bartres-Faz D, Junque C, Moral P, Lopez-Alomar A, Sanchez-Aldeguer J, Clemente IC. Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment. J Neuropsychiatry Clin Neurosci. 2002;14(1):80–83
  6. Bermel RA, Bakshi R, Tjoa C, Puli SR, Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol. 2002;59(2):275–280
  7. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000;343(7):450–456
  8. Burke WJ, Roccaforte WH, Wengel SP. The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4(3):173–178
  9. Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust WJ, et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging. 2003;24(4):537–544
  10. Cervilla J, Prince M, Joels S, Lovestone S, Mann A. Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype. J Neurol Neurosurg Psychiatry. 2004;75(8):1100–1106
  11. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage. 2003;18(2):525–541
  12. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology. 2002;59(5):746–748
  13. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, et al. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol. 2005;62(6):975–980
  14. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001;71(4):441–447
  15. Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, et al. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology. 2003;60(3):481–486
  16. Fleisher A, Grundman M, Jack CR, Petersen RC, Taylor C, Kim HT, et al. Sex, apolipoprotein E epsilon4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol. 2005;62(6):953–957
  17. Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatry. 1983;40(7):812
  18. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 2001;358(9277):201–205
  19. Fox NC, Warrington EK, Rossor MN. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet. 1999;353(9170):2125
  20. Galanis DJ, Joseph C, Masaki KH, Petrovitch H, Ross GW, White L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. Am J Public Health. 2000;90(8):1254–1259
  21. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, et al. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology. 2001;57(8):1461–1466
  22. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, et al. Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology. 1996;46(6):1749–1751
  23. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572
  24. Hyman BT, Van Horsen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 1984;225(4667):1168–1170
  25. Jack CR, Petersen RC, Xu YC, O’Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52(7):1397–1403
  26. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, et al. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer. 2005;13(1):66–69
  27. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997;48(5):1297–1304
  28. Klages J, Fisk JD. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging. Brain Cogn. 2002;49(2):201–204
  29. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology. 2004;63(1):94–100
  30. Lambon Ralph MA, Patterson K, Graham N, Dawson K, Hodges JR. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain. 2003;126(Pt 11):2350–2362
  31. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol. 1994;15(5):929–937
  32. Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL. Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci. 1998;160(1):67–75
  33. Liu L, Guo XE, Zhou YQ, Xia JL. Prevalence of dementia in China. Dement Geriatr Cogn Disord. 2003;15(4):226–230
  34. Mann DM. The pathogenesis and progression of the pathological changes of Alzheimer's disease. Ann Med. 1989;21(2):133–136
  35. Marquis S, Moore MM, Howieson DB, Sexton Q, Payami H, Kaye JA, et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol. 2002;59(4):601–606
  36. Maruyama M, Matsui T, Tanji H, Nemoto M, Tomita N, Ootsuki M, et al. Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways. Arch Neurol. 2004;61(5):716–720
  37. McKhann Q, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944
  38. Meguro K, Ishii H, Yamaguchi S, Ishizaki J, Sato M, Hashimoto R, et al. Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project. Alzheimer Dis Assoc Disord. 2004;18(1):3–10
  39. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3):397–405
  40. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004;63(12):2332–2340
  41. Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002;59(6):867–873
  42. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia. 1995;6(1):21–31
  43. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25(3):303–310
  44. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl. 1):65–69
  45. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308
  46. Petersen RC, Thomas RQ, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379–2388
  47. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hanninen T, Hallikainen M, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology. 1994;44(9):1660–1668
  48. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 2002;59(7):1034–1041
  49. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, et al. The cognitive abilities screening instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45–58(discussion 62)
  50. Tian J, Bucks RS, Haworth J, Wilcock G. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry. 2003;74(4):433–438
  51. Tien RD, Felsberg GJ, Campi de Castro C, Osumi AK, Lewis DV, Friedman AH, et al. Complex partial seizures and mesial temporal sclerosis: evaluation with fast spin-echo MR imaging. Radiology. 1993;189(3):835–842
  52. Tien RD, Felsberg GJ, Crain B. Normal anatomy of the hippocampus and adjacent temporal lobe: high-resolution fast spin-echo MR images in volunteers correlated with cadaveric histologic sections. AJR Am J Roentgenol. 1992;159(6):1309–1313
  53. Tuokko H, Frerichs R, Graham J, Rockwood K, Kristjansson B, Fisk J, et al. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol. 2003;60(4):577–582
  54. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res. 1990;83:445–457
  55. Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 1999;246(6):477–485
  56. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry. 2002;72(4):491–497
  57. Wang PN, Wang SJ, Fuh JL, Teng EL, Liu CY, Lin CH, et al. Subjective memory complaint in relation to cognitive performance and depression: a longitudinal study of a rural Chinese population. J Am Geriatr Soc. 2000;48(3):295–299
  58. Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res. 2002;924(1):113–115
  59. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, et al. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002;59(7):1154–1160
  60. Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues JF. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. J Neurol Neurosurg Psychiatry. 2002;72(6):794–797
  61. Wolf H, Hensel A, Kruggel F, Riedel-Heller SQ, Arendt T, Wahlund LO, et al. Structural correlates of mild cognitive impairment. Neurobiol Aging. 2004;25(7):913–924
  62. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl. 2003;179:52–76
  63. Xanthakos S, Krishnan KR, Kim DM, Charles HC. Magnetic resonance imaging of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(4):597–626
  64. Xu Y, Jack CR, O’Brien PC, Kokmen E, Smith GE, Ivnik RJ, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54(9):1760–1767
  65. Yamaguchi S, Meguro K, Shimada M, Ishizaki J, Yamadori A, Sekita Y. Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project. Neuroradiology. 2002;44(1):43–48

PII: S0197-4580(05)00316-7

doi: 10.1016/j.neurobiolaging.2005.10.002

Neurobiology of Aging
Volume 27, Issue 12 , Pages 1797-1806 , December 2006

Article Tools

* Image Usage & Resolution